Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 5Thoracic 2Plasma cell 2Head & Neck 2Gastrointestinal 2CNS 2NET 1Lymphoid 1Gynecologic 1Genitourinary 1Endocrine 1Breast 1

Conditions

Multiple Myeloma 940Lymphoma 113Recurrence 94Neoplasms, Plasma Cell 92Lymphoma, Non-Hodgkin 69Immunoglobulin Light-chain Amyloidosis 60Hematologic Neoplasms 60Neoplasms 54Smoldering Multiple Myeloma 52Leukemia, Myeloid, Acute 51Leukemia 51Myelodysplastic Syndromes 47Leukemia, Lymphocytic, Chronic, B-Cell 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Hodgkin Disease 38Leukemia, Plasma Cell 27Myeloproliferative Disorders 24Breast Neoplasms 24Monoclonal Gammopathy of Undetermined Significance 23Lymphoma, Large B-Cell, Diffuse 23Lymphoma, Mantle-Cell 22Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Amyloidosis 22Primary Myelofibrosis 21Lymphoma, Follicular 21Waldenstrom Macroglobulinemia 20Ovarian Neoplasms 20Lymphoma, B-Cell, Marginal Zone 17Lymphoma, B-Cell 17Colorectal Neoplasms 17

Interventions

selinexor 1repotrectinib 1pazopanib 1Suspensions 1Proton Therapy 1Ifosfamide 1Doxorubicin 1Capsules 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Solitary Fibrous Tumors × Plasma cell × 1 year × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

NCT04094610 2025-11-19

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Turning Point Therapeutics, Inc.

Phase 1/2 Recruiting
75 enrolled
CNSLymphoidPlasma cellSarcoma

Glioblastoma, Glioma, Granuloma, Plasma Cell, Lymphoma, Neoplasm Metastasis, Sarcoma, Lymphoma, Large-Cell, Anaplastic, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡